NCT01450098 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

A Study of LY2484595 in Healthy Subjects


Sponsors: Eli Lilly and Company	Phases: Phase I
Indications	Acronym:
Healthy Volunteers
Age Groups: Adult	Gender: Both
Names: Drug: LY2484595 Reference Formulation (RF) Drug: LY2484595 spray-dried solid dispersion-propyl gallate (SDSD-PG)	Enrollment: 45

Additional information about NCT01450098.